Kissing Nevus (Also Called âDivided Nevusâ)
What is Kissing nevus?
A kissing nevus, also known as a divided nevus or split nevus, is a benign (nonâcancerous) pigmented mole that appears on two adjacent skin surfaces that touch each other. The classic example is a mole that is split between the upper and lower eyelids, so each half looks like it is âkissingâ the other when the eyes are closed. The term âkissingâ refers to the way the two halves line up perfectly when the adjoining surfaces come together.
These lesions are usually present at birth or become evident in early childhood, although they may be noticed later when the skin stretches during growth or puberty. Although they are almost always harmless, a kissing nevus can cause cosmetic concerns or, rarely, may evolve into melanoma, the same risk that applies to any pigmented mole.
Common Causes
Kissing nevi are not caused by an external factor; they arise from developmental processes during embryogenesis. The following conditions or factors are linked to their formation:
- Embryologic fusion of tissue planes â As the eyelids (or other paired structures) develop, melanocytes can become trapped on both sides of the separating membrane.
- Neural crest cell migration â Melanocytes originate from neural crest cells that travel to the skin; errors in their migration can leave pigment cells on both sides of a split surface.
- Congenital melanocytic nevus â A larger birthâmark that may become divided when the skin folds or fuses during development.
- Genetic predisposition â Certain families have a higher incidence of congenital nevi, suggesting a hereditary component.
- Postâzygotic somatic mutation â Mutations that occur after fertilization can affect only a portion of cells, resulting in localized pigment changes.
- Trauma during fetal development â Mechanical forces that separate tissue layers may split an existing nevus.
- Hormonal influences â Puberty or pregnancy can cause existing nevi (including divided ones) to darken or enlarge.
- Sun exposure (postânatal) â While UV light does not create the split, it can accentuate pigment, making the nevus more noticeable.
- Associated syndromes (rare) â Conditions such as Neurofibromatosis type 1 can feature multiple congenital nevi, though a true kissing nevus is still uncommon.
- Idiopathic â In many cases, no specific cause can be identified beyond normal embryologic development.
Associated Symptoms
Because a kissing nevus is a pigmented skin lesion, it usually does not produce symptoms. However, the following observations may accompany it:
- Changes in size, shape, or color over time.
- Itching or mild tenderness, especially if the lesion becomes irritated by rubbing (e.g., eyelid rubbing).
- Bleeding or crusting after trauma.
- Cosmetic concern, particularly when the nevus is on the face or eyelids.
- Rarely, a sensation of âprickingâ if the lesion is located near a nerveârich area.
When to See a Doctor
Most kissing nevi are benign and require only routine observation, but you should schedule an appointment if you notice any of the following:
- Rapid growth in diameter over weeks to months.
- Asymmetrical borders or an irregular shape.
- New colors (especially shades of red, blue, or black) appearing within the mole.
- Bleeding, ulceration, or crust that does not heal.
- Persistent itching, pain, or a burning sensation.
- Any change in the way the two halves align when the surfaces touch.
- Family history of melanoma or other skin cancers.
Early evaluation is important because, although rare, melanoma can arise from a congenital nevus.
Diagnosis
Evaluation of a kissing nevus typically follows the same steps used for other pigmented lesions:
1. Clinical Examination
The dermatologist will inspect the lesion with a magnifying dermatoscope, looking for the ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter >6âŻmm, Evolution).
2. Patient History
Key questions include: age of onset, any changes over time, family skinâcancer history, and any prior trauma or irritation.
3. Dermoscopy
This nonâinvasive tool magnifies surface structures and pigment patterns, helping differentiate benign nevi from atypical or malignant lesions.
4. Digital Monitoring
Highâresolution photographs taken at regular intervals (every 6â12âŻmonths) allow both patient and clinician to track subtle changes.
5. Biopsy (if indicated)
If the lesion shows worrisome features, a dermatologist may perform a punch or excisional biopsy. Histopathology confirms whether the cells are benign melanocytes or indicative of melanoma.
Treatment Options
Because a kissing nevus is usually harmless, treatment is often optional and driven by cosmetic preference or medical necessity.
Observation
For most patients, âwatchful waitingâ with regular skin checks is sufficient. This involves:
- Annual dermatologist visits.
- Selfâexamination at home.
- Photographic documentation.
Surgical Excision
When removal is desired (cosmetic reasons or suspicion of malignancy), the two halves can be excised together or staged:
- Standard excision with primary closure â works well for small lesions.
- Local flap or graft â used for larger lesions, especially on the eyelids, to preserve function and appearance.
- Laserâassisted removal â COâ or Er:YAG lasers can ablate superficial pigment with minimal scarring, though they do not provide tissue for pathology.
Cryotherapy
Freezing the nevus with liquid nitrogen can lighten pigment. This is typically reserved for small, superficial lesions and is not suitable for lesions near the eye.
Topical Treatments (Adjunctive)
- Hydroquinone or azelaic acid â May lighten superficial pigmentation, but effectiveness on nevi is limited.
- Retinoids (tretinoin) â Can promote turnover of pigmented cells, again mostly cosmetic.
Topical agents do not replace surgical removal if malignancy is a concern.
Followâup Care
After any procedure, protect the area with sunscreen (SPFâŻ30+), avoid rubbing, and keep the wound clean. Sutures on the eyelids are typically removed within 5â7âŻdays.
Prevention Tips
Because a kissing nevus forms during fetal development, true primary prevention is not possible. However, you can reduce the risk of complications and secondary changes:
- Sun protection â Apply broadâspectrum sunscreen daily and wear wideâbrimmed hats or UVâblocking sunglasses.
- Avoid trauma â Do not rub, pick, or scratch the lesion.
- Regular skin checks â Perform a selfâexam at least once a month and visit a dermatologist annually.
- Healthy lifestyle â Adequate nutrition and hydration support skin health.
- Educate family members â If a child has a kissing nevus, teach them not to irritate the area.
Emergency Warning Signs
Seek immediate medical attention if you experience any of the following:
- Sudden, rapid growth of the nevus within days.
- Bleeding that does not stop after applying pressure for 10âŻminutes.
- Severe pain, especially if accompanied by visual changes when the nevus is on the eyelid.
- Ulceration or an open sore that becomes infected (redness, warmth, pus).
- Signs of systemic illness such as fever, unexplained weight loss, or night sweats together with changes in the lesion.
If any of these redâflag symptoms occur, go to the nearest emergency department or urgent care center right away.
Key Takeâaways
- Kissing nevus is a benign, congenital pigmented mole split between two adjoining skin surfaces, most often the upper and lower eyelids.
- It develops from embryologic migration of melanocytes; there is no lifestyle cause.
- Most people never need treatmentâroutine observation is sufficient.
- Watch for ABCDE changes; any suspicious evolution warrants prompt dermatologic evaluation.
- Surgical excision, laser removal, or cryotherapy are options for cosmetic or diagnostic reasons.
- Sun protection and avoiding trauma help prevent secondary changes.
- Emergency signs include rapid growth, uncontrolled bleeding, pain with visual changes, or infection.
For personalized advice, always consult a boardâcertified dermatologist or ophthalmologist familiar with periâocular lesions. Information in this article is based on guidelines from the Mayo Clinic, the CDC, the NIH, the Cleveland Clinic, and peerâreviewed dermatology literature.
```